Welcome : Guest

Intellipharmaceutics International, Inc. (Canada) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Intellipharmaceutics International, Inc., which is principally involved in Pharmaceuticals Business. Illustrated with 72 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-64653
Price: $3500
Company Type: Public
Pages: 74
Date: November 2016
Market Data Tables: 72

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Anti-Psychotics......3
Table 1: Anti-Psychotics Market Worldwide (2015-2020) in US$ '000......3
Table 2: Anti-Psychotic Market by Drug Type Worldwide (2015) - Percentage Share Breakdown by Value for Abilify, Abilify Maintena, Invega Sustenna, Latuda, Risperdal Consta, Seroquel XR, and Others......4
Table 3: Prescribed Atypical Antipsychotic Market by Type in the US (2015) - Percentage Share Breakdown by Value for 5HT1A Agonist, H1, Antagonist, D2 and 5HT2, D2 and 5HT2A, and Partial D2 Agonist......5
Table 4: Antipsychotic Drugs Market by Disorder in the US (2015) - Percentage Breakdown by Value for Anxiety, Bipolar, Disorder, Major, Depression, Schizoaffective Disorder, Schizophrenia, and Other Indications......6
Table 5: Market Shares of Leading Prescribed Atypical Antipsychotic Brands in the US (2015) - Percentage Share Breakdown by Value for Abilify, Invega, Latuda, Risperdal, Seroquel, and Others......7
Adult Non-Stimulant Drugs......8
Table 6: Adult Non-Stimulant Drugs Market by Prescription Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kapvay, and Strattera......8
Stimulant Drugs......9
Table 7: Branded Stimulant Drugs Market by Prescription Worldwide (2015) - Percentage Share Breakdown by Value for Adderall XR, Focalin XR, Vyvanse and Others......9
Table 8: Pediatric Non-Stimulant Drugs Market by Prescription Worldwide (2015) - Percentage Share Breakdown by Value Sales for Intunniv, Kapvay, and Strattera......10
Topiramate Drugs......11
Table 9: Topiramate Drug Usage by Indication in the US (2015) - Percentage Market Share Breakdown by Volume for Epilepsy, Migraine Headache, Psychiatric Disorders, Weight Loss, and Others......11
Table 10: Topiramate Drug Usage by Prescriber in the US (2015) - Percentage Market Share Breakdown by Volume for Family Practice, Internal Medicine & Pediatrics, Neurology, Nurse, Osteopathic Medicine, Psychiatry, and Others......12
Pharmaceuticals......13
Table 11: Pharmaceuticals Market by Product in the US (2015) - Percentage Share Breakdown by Value Sales for Abilify, AdvairDiskus, Crestor, Cymbalta, Enbrel, Humira, Nexium, Remicade, and Others......13
Oxcarbazepine......14
Table 12: Oxcarbazepine Drug Usage by Indication in the US (2015) - Percentage Market Share Breakdown by Volume for Epilepsy, Psychiatric Disorders and Others......14
Table 13: Oxcarbazepine Drug Usage by Prescriber in the US (2015) - Percentage Market Share Breakdown by Volume for Internal Medicine & Pediatrics, Neurology, Nurse, Psychiatry, and Others......15
Immunostimulants......16
Table 14: Immunostimulants Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Interferon α-2a, Lentinan, RhG-CSF, Thymopentin, Thymosin α1, and Others......16
Methylphenidate......17
Table 15: Methylphenidate Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Concerta, Dexmethylphenidate Extended-Release, Focalin XR, Methylphenidate Extended-Release (ER), Methylphenidate Immediate-Releade (IR) and Others......17
Anti-Thrombotics......18
Table 16: Anti-Thrombotic Sales by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Clopidogrel, Dabigatran, Lovenox, Prasugrel, Rivaroxaban, Ticagrelor, and Autres......18
Central Nervous System (CNS) Drugs......19
Table 17: Central Nervous System (CNS) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Depression, Epilepsy, Narcotic Analgesics, Non-Narcotic Analgesics, Psychotic Disorders and Others......19
Table 18: Central Nervous System Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anti-Migraine, Antipsychotics, Newer Antidepressants, Older Antidepressants, SNRI's, SSRI’s, Tranquilizers, and Others......20
Depression Drugs......21
Table 19: Depression Drugs Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Bupropion Hydrochloride XL, Cymbalta, Escitalopram Oxalate, Lexapro, Pristiq, and Others......21
Diabetes Drugs......22
Table 20: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......22
Table 21: Diabetes/Metabolic Drugs Market by Category Worldwide (2015) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......23
Table 22: Anti-Diabetic Drug Market by Treatment Class Worldwide (2015) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......24
Table 23: Antidiabetes Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......25
Table 24: Anti-Diabetic Drugs Market in China (2015-2020) in RMB Million......26
Table 25: Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glinide, Insulin, Sulfonylureas, α-glucosidase Inhibitor, and Others......27
Table 26: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......28
Table 27: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......29
Table 28: Diabetic Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for DPP-IV & SGLT-2, GLP-1, Insulins, and Others......30
Table 29: Diabetic Drugs Market by Non-Insulin Therapy in the US (2015) - Percentage Share Breakdown by Volume for Biguanides, DPP-4 Inhibitor, Human GLP-1 Analogs, SGLT-2 Inhibitor, Sulfonylureas, and Others......31
Table 30: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......32
Non-Insulin Anti-Diabetic Drugs......33
Table 31: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......33
Epilepsy Drugs......34
Table 32: Epilepsy Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Carbamazepine Generics, Depakote/ER Franchise (ABT), Depakote/ER Generics, Dilant in (PFE), Gabapent in Generics, Keppra Generics, Keppra/XR (UCB), Lamictal/XR (GSK), Lyrica (PFE), Trileptal (NVS), Vimpat (UCB), and Others......34
Gastrointestinal Drugs......35
Table 33: Gastrointestinal Market Worldwide (2015) in US$ Million......35
Table 34: Gastrointestinal Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for H2 Blockers, Proton Pump Inhibitors, and Others......36
Generic Drugs......37
Table 35: Generics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, India, North America, Russia and Other CIS and Rest of the World......37
Table 36: Generic Pharmaceuticals Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Diabetes, Hormonal Drugs, Oncology, Respiratory, Rheumatology, and Others......38
Non-Stimulant Drugs......39
Table 37: Non-Stimulant Drugs Market by Prescription Worldwide (2015) - Percentage Share Breakdown by Value for Intunniv, Kapvay, and Strattera......39
Over the Counter (OTC) Drugs......40
Table 38: OTC Market (Private Label and Others) by Region Worldwide (2015) - Percentage Share Breakdown by Values Sales for Australia, Canada, Chile, France, Germany, Israel, Japan, Netherlands, Russia, United Kingdom, USA and Rest of the World......40
Table 39: OTC Drug Sales by Category in China (2015) - Percentage Market Share Breakdown by Value for Anti-Inflammatory, Cold, Gastrointestinal, Gynecological, Minerals, Tonics, Vitamins, Supplements, and Others......41
Table 40: OTC Drugs Market by Channel in China (2015) - Percentage Share Breakdown by Value Sales for Clinics, Community Hospital, General Hospital, Pharmacy, Supermarket, and Others......42
Table 41: Over - The - Counter (OTC) Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for Cough, Cold, Allergy & Sinus, Digestives, Pain Relief, Vitamins & Supplements, Weight Loss & Nutritional Meal Replacements and Others......43
Pain Drugs......44
Table 42: Pain Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Fentanyl, Hydrocordone, Acetaminophen, Lidoderm, Lyrica, OpanaER, Oxycotin, and Others......44
Proton Pump Inhibitor (PPI) Drugs......45
Table 43: Proton Pump Inhibitor (PPI) Drugs Market by Category in the US (2015) - Percentage Market Share Breakdown by Value Sales for Aciphex (JNJ/Eisai), Dexilant (Takeda), Generic Prilosec, Nexium (AZN), Prevacid (Takeda), Prilosec, Protonix (PFE/WYE), and Others......45
Table 44: Ulcer Drugs by Category in the US (2015) - Percentage Share Breakdown by Number of Prescriptions for H2 Blockers, Proton Pump Inhibitors, and Others......46
Antipsychotics......47
Table 45: New Prescription Market for Atypical Antipsychotic Drugs in the US (2015) - Percentage Share Breakdown by Value Sales for Abilify (Otsuka/ Bristol-Myers Squibb Company), Fanapt (Novartis), Geodon (Pfizer, Inc.), Invega (Johnson & Johnson), Latuda (Sunovion), Olanzapine (Generic Zyprexa), Risperidone (Generic Risperdal), Saphris (Merck & Company, Inc.), Seroquel (AstraZeneca Plc), and Zyprexa (Eli Lilly and Company)......47
Table 46: Market Shares of Leading Prescribed Atypical Antipsychotic Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Sunovion Pharmaceuticals, Inc., and Johnson & Johnson Private Limited......48
Central Nervous System (CNS) Medicines......49
Table 47: Market Shares of Leading Central Nervous System Medicine Manufacturers by Value Sales Worldwide (2015) - Percentage Breakdown for AstraZeneca Plc (AZN), Bristol-Myers Squibb Company (BMY), Eli Lilly And Co (LLY), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Novartis AG (NVS), Pfizer, Inc. (PFE), Shire Plc (SHPGY), and Others......49
Table 48: Market Shares of Leading Central Nervous System (CNS) Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......50
Diabetes Drugs......51
Table 49: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......51
Table 50: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......52
Table 51: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......53
Epilepsy Therapeutics......54
Table 52: Market Shares of Leading Epilepsy Medicine Manufacturers by Value Sales Worldwide (2015) - Percentage Breakdown for GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......54
Gastrointestinal Drugs......55
Table 53: Market Shares of Leading Gastrointestinal, Ulcer Medicine Manufacturers by Value Sales Worldwide (2015) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Pfizer, Inc., and Others......55
Table 54: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......56
Table 55: Market Shares of Leading Gastrointestinal (GI) Remedies Manufacturers for Over- the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for GlaxoSmithKline Pharmaceuticals Limited, Johnson & Johnson Private Limited, Novartis Consumer Health, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Private Label and Others......57
Table 56: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......58
Table 57: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Volume Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......59
Over the Counter (OTC) Drugs......60
Table 58: Market Shares of Leading Over the Counter (OTC) Drugs Manufacturers in Brazil (2015) - Percentage Share Breakdown by Value for Abbott Laboratories, GlaxoSmithKline, Johnson & Johnson, Sanofi-Aventis and Others......60
Table 59: Market Shares of Leading Over The Counter (OTC) Drugs Manufacturers in Indonesia (2015) - Percentage Share Breakdown by Value for PT Kalbe Farma and Others......61
Table 60: Market Shares of Leading Over the Counter Drugs Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline-Novartis International AG, Johnson & Johnson and Others......62
Pain Management Drugs......63
Table 61: Market Shares of Leading Pain Management Therapeutic Providers by Value Sales Worldwide (2015) - Percentage Breakdown for AstraZeneca Plc, Endo International Plc, Johnson & Johnson, Pfizer, Inc., and Others......63
Table 62: Market Shares of Leading Pain Remedies Manufacturers for Over-the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for Bayer HealthCare AG, Johnson & Johnson Private Limited, Pfizer, Inc., Prestige Brands Holdings, Inc., Private-label and Others......64
Table 63: Market Shares of Leading Pain Remedy Producers Sales in the US OTC Market (2015) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., Prestige Brands Holdings, Inc., Private Label and Others......65
Table 64: Market Shares of Leading Oral Pain Relief Brands through Food Store in the US (2015) - Percentage Share Breakdown by Value for Anbesol, Baby Orajel, Kank A, Kank A Softbrush, Orajel, Private Label, and Others......66
Table 65: Market Shares of Leading Oral Pain Relief Brands through Supermarkets, Drugstores, Mass Merchandisers (including Wal-Mart), Gas & Convenience Stores, Military Commissaries, and Select Club and Dollar Retail Chains in the US (2015) - Percentage Share Breakdown by Value for Anbesol, BabyOrajel, Hyland's, KankA, Orajel, and Other......67
Table 66: Market Shares of Leading Oral Pain Remedy Brands by Value Sales through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Share Breakdown for Anbesol, Baby Orajel, Glyoxide, Kank-A, Orajel, Private Label, and Others......68
Prescription Pharmaceuticals......69
Table 67: Market Shares of Leading Prescription Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Volume Sales for Dexa Medica Group, Interbat Pharmaceutical Industry PT, PT Kalbe Farma, Tbk, PT Sanbe Farma, and Others......69
Table 68: Market Shares of Leading RX Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Eurofarma Laboratórios, Hypermarcas S.A.,Pfizer, Inc., Roche AG, Sanofi - Medley Indústria Farmacêutica Ltda and Others......70
Table 69: Market Shares of Leading Prescription Pharmaceutical Companies in the US (2014) - Percentage Market Share Breakdown by Volume Sales for Actavis Plc, Amneal, Inc., Endo Pharma, Inc., Lupin Pharmaceuticals, Inc., Mylan Labs,Inc., Novartis International AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and Others......71
Table 70: Market Shares of Leading Prescription Drug Companies in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries, Ltd., and Others......72
Table 71: Market Shares of Leading Prescription Drug Companies Spending through Media Ads in the US (2015) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......73
Lamotrigine Tablets......74
Table 72: Market Shares of Leading Lamotrigine Tablet Brands in Brazil (2015) - Percentage Share Breakdown by Value for Cristalia- Neural, Eurofarma- Leptico, GSK- Lamictal, and Torrent- Lamitor......74